These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8929738)

  • 21. Chromosome one polymorphism in a girl with the Chediak-Higashi syndrome.
    Salamanca-Gómez F; Salazar-Mallen M; Amezcua ME
    Acta Cytol; 1978; 22(5):402-5. PubMed ID: 281851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
    Holcombe RF
    Acta Haematol; 1992; 87(1-2):45-8. PubMed ID: 1533985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.
    Cifaldi L; Pinto RM; Rana I; Caniglia M; Angioni A; Petrocchi S; Cancrini C; Cursi L; Palumbo G; Zingoni A; Gismondi A; Rossi P; Santoni A; Cerboni C
    Immunol Lett; 2016 Dec; 180():46-53. PubMed ID: 27816481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
    Haliotis T; Roder J; Klein M; Ortaldo J; Fauci AS; Herberman RB
    J Exp Med; 1980 May; 151(5):1039-48. PubMed ID: 6154765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new immunodeficiency disorder in humans involving NK cells.
    Roder JC; Haliotis T; Klein M; Korec S; Jett JR; Ortaldo J; Heberman RB; Katz P; Fauci AS
    Nature; 1980 Apr; 284(5756):553-5. PubMed ID: 6445041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1.
    Dufourcq-Lagelouse R; Lambert N; Duval M; Viot G; Vilmer E; Fischer A; Prieur M; de Saint Basile G
    Eur J Hum Genet; 1999 Sep; 7(6):633-7. PubMed ID: 10482950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of natural killer cell activity].
    Abo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Microtubular defect in Chediak-Higashi syndrome.
    Hinds K; Danes BS
    Lancet; 1976 Jul; 2(7977):146-7. PubMed ID: 59209
    [No Abstract]   [Full Text] [Related]  

  • 32. The Chediak-Higashi syndrome and the homologous trait in animals.
    Windhorst DB; Padgett G
    J Invest Dermatol; 1973 Jun; 60(6):529-37. PubMed ID: 4575899
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement of deficient natural killer activity and delayed bactericidal activity by a thiol proteinase inhibitor, E-64-d, in leukocytes from Chediak-Higashi syndrome patients in vitro.
    Tanabe F; Kasai H; He L; Kin T; Fujikado T; Kumamoto T; Hara T; Iwata T; Ito M
    Int Immunopharmacol; 2009 Mar; 9(3):366-70. PubMed ID: 19185618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-delta T cells in Chediak-Higashi syndrome.
    Holcombe RF; van de Griend R; Ang SL; Bolhuis RL; Seidman JG
    Acta Haematol; 1990; 83(4):193-7. PubMed ID: 2115716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon and natural killer cells].
    Saksela E
    Duodecim; 1980; 96(16):1061-4. PubMed ID: 6164530
    [No Abstract]   [Full Text] [Related]  

  • 36. [Albinism, thrombopathy, ceroid storage disease--Hermansky-Pudlak syndrome. Overview and description with immunodeficiency].
    Berz F; Weiss M; Belohradsky BH
    Klin Padiatr; 1996; 208(2):83-7. PubMed ID: 8901188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell activity in fawn-hooded rats.
    Starkey JR; Prieur DJ; Ristow SS
    Experientia; 1983 Mar; 39(3):308-10. PubMed ID: 6825800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited disorders of pigmentation.
    Witkop CJ
    Clin Dermatol; 1985; 3(1):70-134. PubMed ID: 3938679
    [No Abstract]   [Full Text] [Related]  

  • 39. Natural killer cells.
    Kay NE
    Crit Rev Clin Lab Sci; 1986; 22(4):343-59. PubMed ID: 2419034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.